Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | NUDT1 | P36639 | 3/20 | 0.44 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.43 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.43 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.39 |
| ▸ | HTR3B | O95264 | 1/20 | 0.39 |
| ▸ | HTR3A | P46098 | 1/20 | 0.39 |
| ▸ | BACE1 | P56817 | 1/20 | 0.39 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.39 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.39 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.36 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL539008 | 0.79 | KDM4E (0.53) | KDM4ETYRO3DYRK1BHSD17B10CSNK1A1 | |
| SCHEMBL31561546 | 0.79 | ALDH1A1 (0.53) | KDM4ENUDT1HTR3EHTR3BHTR3A | |
| SCHEMBL237122 | 0.79 | ALDH1A1 (0.53) | KDM4ENUDT1HTR3EHTR3BHTR3A | |
| SCHEMBL369014 | 0.76 | KDM4E (0.50) | KDM4ETYRO3DYRK1B | |
| SCHEMBL15718879 | 0.76 | KDM4E (0.50) | KDM4ETYRO3DYRK1B | |
| SCHEMBL1551605 | 0.76 | NUDT1 (0.44) | KDM4ENUDT1ALDH1A1MEN1KMT2A | |
| SCHEMBL1551962 | 0.76 | KDM4E (0.50) | KDM4ETYRO3DYRK1BALDH1A1 | |
| SCHEMBL30175417 | 0.76 | ALDH1A1 (0.46) | KDM4ENUDT1PTPN11ALDH1A1MEN1 | |
| SCHEMBL15571871 | 0.72 | KDM4E (0.46) | KDM4ENUDT1TYRO3DYRK1BALDH1A1 | |
| SCHEMBL18114688 | 0.71 | KDM4E (0.46) | KDM4ETYRO3DYRK1BKMT2AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1544434-A | 6-benzylaminopurine production process | 宝应县润扬化工有限公司 | 2004-11-10 | — | — | CN | claimed |
| JP-10218880-A | — | — | None | — | — | JP | disclosed |
| JP-6116266-A | — | — | None | — | — | JP | disclosed |
| EP-4658280-A2 | SIX MEMBERED RING CONTAINING OLIGOMERS | Alnylam Pharmaceuticals, Inc. (US) | 2025-12-10 | — | — | EP | disclosed |
| WO-2024163762-A2 | SIX MEMBERED RING CONTAINING OLIGOMERS | ALNYLAM PHARMACEUTICALS, INC. (US) | 2024-08-08 | — | — | WO | disclosed |
| CN-1592792-B | Materials and methods for detection of nucleic acids | ERAGEN BIOSCIENCES INC | 2010-12-01 | — | — | CN | disclosed |
| US-7560550-B2 | Method for the production of OH protected[4-(2.6-diamino-9H-purine-9-yl)-1.3-dioxolane-2-yl]methanol derivatives | RFS PHARMA, LLC (US) | 2009-07-14 | — | — | US | disclosed |
| WO-2008154286-A2 | MODULATION OF CHEMOSENSORY RECEPTORS AND LIGANDS ASSOCIATED THEREWITH | SENOMYX, INC. (US) | 2008-12-18 | — | — | WO | disclosed |
| US-20080306076-A1 | MODULATION OF CHEMOSENSORY RECEPTORS AND LIGANDS ASSOCIATED THEREWITH | SENOMYX, INC. (US) | 2008-12-11 | — | — | US | disclosed |
| US-7189849-B2 | Synthesis of acyclic nucleoside derivatives | MEDIVIR AB (SE) | 2007-03-13 | — | — | US | disclosed |
| CN-1592792-A | Materials and methods for detection of nucleic acids | ERAGEN BIOSCIENCES INC (US) | 2005-03-09 | — | — | CN | disclosed |
| US-20040248910-A1 | Synthesis of acyclic nucleoside derivatives | MEDIVIR AB (SE) | 2004-12-09 | — | — | US | disclosed |
| CN-1544434-A | 6-benzylaminopurine production process | 宝应县润扬化工有限公司 | 2004-11-10 | — | — | CN | disclosed |
| US-20040024214-A1 | Synthesis of acyclic nucleoside derivatives | MEDIVIR AB (SE) | 2004-02-05 | — | — | US | disclosed |
| US-6613936-B1 | Herpes and retroviral infections; diester derivatives of H2G bearing specific combinations of an amino acid ester and a fatty acid ester, improved oral bioavailability; 9-(2-(butyryloxymethyl)-4-(L-isoleucyloxy)butyl)guanine | MEDIVIR AB (SE) | 2003-09-02 | — | — | US | disclosed |
| EP-1131323-A1 | SYNTHESIS OF ACYCLIC NUCLEOSIDE DERIVATIVES | Medivir Aktiebolag (SE) | 2001-09-12 | — | — | EP | disclosed |
| US-6184376-B1 | POTENT ANTIVIRALS, ESPECIALLY AGAINST HERPES INFECTIONS, SUCH AS THOSE CAUSED BY VARICELLA ZOSTER VIRUS, HERPES SIMPLEX, EPSTEIN-BARR VIRUS, HERPES TYPE 6 (HHV-6) AND TYPE 8 (HHV-8). SHINGLES IN THE ELDERLY OR CHICKEN POX IN THE YOUNG | MEDIVER AB (SE) | 2001-02-06 | — | — | US | disclosed |
| WO-2000008025-A1 | SYNTHESIS OF ACYCLIC NUCLEOSIDE DERIVATIVES | MEDIVIR AB (SE) | 2000-02-17 | — | — | WO | disclosed |
| JP-H10218880-A | PRODUCTION 2-AMINOPURINE DERIVATIVE | SUMIKA FINE CHEM KK | 1998-08-18 | — | — | JP | disclosed |
| JP-H06116266-A | PRODUCTION OF 2-AMINO-6-ALKOXYPURINE | NIPPON KAYAKU CO LTD | 1994-04-26 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080306076-A1 | MODULATION OF CHEMOSENSORY RECEPTORS AND LIGANDS ASSOCIATED THEREWITH | OR51E2, TAS2R50, TAS2R30 | KDM4E 4397/4885NUDT1 3962/4885TYRO3 1293/4885 |
| US-20040024214-A1 | Synthesis of acyclic nucleoside derivatives | NSUN2, SLC28A1, NUDT1 | KDM4E 4410/4885NUDT1 3/4885TYRO3 4390/4885 |
| US-20040248910-A1 | Synthesis of acyclic nucleoside derivatives | NSUN2, SLC28A1, NUDT1 | KDM4E 4410/4885NUDT1 3/4885TYRO3 4390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.